RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
-0.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.76B
AUM Growth
+$4.76B
Cap. Flow
+$78.2M
Cap. Flow %
1.64%
Top 10 Hldgs %
26.26%
Holding
166
New
11
Increased
69
Reduced
16
Closed
13

Top Buys

1
BAX icon
Baxter International
BAX
$36.2M
2
WRBY icon
Warby Parker
WRBY
$34.5M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
$30.3M
4
IMRX icon
Immuneering
IMRX
$28.9M
5
ASND icon
Ascendis Pharma
ASND
$26.5M

Top Sells

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$68.6M
2
ARDX icon
Ardelyx
ARDX
$39.8M
3
BIIB icon
Biogen
BIIB
$39.3M
4
BSX icon
Boston Scientific
BSX
$34.2M
5
PPD
PPD, Inc. Common Stock
PPD
$31.1M

Sector Composition

1 Healthcare 93.53%
2 Consumer Staples 1.58%
3 Industrials 0.82%
4 Financials 0.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EDAP
126
EDAP TMS
EDAP
$84.5M
$4.86M 0.1% 760,900 – –
ATAI icon
127
ATAI Life Sciences
ATAI
$982M
$4.7M 0.1% 317,628 +2,600 +0.8% +$38.5K
GRTX
128
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$4.6M 0.1% 568,252 – –
TPST icon
129
Tempest Therapeutics
TPST
$44M
$4.49M 0.09% 310,161 – –
EPIX icon
130
ESSA Pharma
EPIX
$11.4M
$4.06M 0.09% 508,044 +5,009 +1% +$40.1K
TLPH icon
131
Talphera
TLPH
$11.1M
$3.9M 0.08% 3,819,402 +30,645 +0.8% +$31.3K
INNV icon
132
InnovAge Holding
INNV
$517M
$3.47M 0.07% 525,000 -377,500 -42% -$2.5M
ELVN icon
133
Enliven Therapeutics
ELVN
$1.2B
$3.38M 0.07% +829,102 New +$3.38M
BLSA
134
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$3.08M 0.06% 309,000 – –
BCEL
135
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2.87M 0.06% 459,830 – –
NUVB icon
136
Nuvation Bio
NUVB
$1.02B
$2.35M 0.05% 236,609 -4,876 -2% -$48.5K
PSTX
137
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.11M 0.04% 289,754 – –
PRDS
138
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$2.08M 0.04% 209,332 – –
EUCRU
139
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$2.05M 0.04% 206,000 – –
TMPMU
140
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
$2.05M 0.04% 206,000 – –
PHICU
141
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$2.01M 0.04% 201,044 – –
JYAC
142
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$2.01M 0.04% 206,200 – –
MLTX icon
143
MoonLake Immunotherapeutics
MLTX
$3.54B
$1.54M 0.03% 154,500 – –
APLS icon
144
Apellis Pharmaceuticals
APLS
$3.48B
$872K 0.02% +26,458 New +$872K
NUVB.WS icon
145
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$343K 0.01% 134,028 – –
ACAD icon
146
Acadia Pharmaceuticals
ACAD
$4.38B
– – -1,000,000 Closed -$24.4M
ADPT icon
147
Adaptive Biotechnologies
ADPT
$2.01B
– – -650,000 Closed -$26.6M
ARDX icon
148
Ardelyx
ARDX
$1.53B
– – -5,248,829 Closed -$39.8M
BIIB icon
149
Biogen
BIIB
$19.4B
– – -113,500 Closed -$39.3M
BSX icon
150
Boston Scientific
BSX
$156B
– – -800,000 Closed -$34.2M
3 4 5
6
7